Brain Health Roundtable and AADAPT Act

<table class="infobox infobox-entity">
<tr>
<th class="infobox-header" colspan="2">Brain Health Roundtable & AADAPT Act</th>
</tr>
<tr>
<td class="label">Date Announced</td>
<td>March 17, 2026</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Policy Initiatives</td>
</tr>
<tr>
<td class="label">Lead Organizations</td>
<td>Alzheimer's Association, U.S. Senate</td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Brain Health, Dementia Workforce Training</td>
</tr>
</table>

Brain Health Roundtable and AADAPT Act

Overview

<table class="infobox infobox-entity">
<tr>
<th class="infobox-header" colspan="2">Brain Health Roundtable & AADAPT Act</th>
</tr>
<tr>
<td class="label">Date Announced</td>
<td>March 17, 2026</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Policy Initiatives</td>
</tr>
<tr>
<td class="label">Lead Organizations</td>
<td>Alzheimer's Association, U.S. Senate</td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Brain Health, Dementia Workforce Training</td>
</tr>
</table>

Brain Health Roundtable and AADAPT Act

Overview

March 2026 marked two significant policy developments in the Alzheimer's and dementia care landscape in the United States. The [Alzheimer's Association](/institutions/alzheimers-association) launched the Brain Health Roundtable, a cross-sector coalition dedicated to elevating brain health as a national public health priority. Simultaneously, the U.S. Senate reintroduced the AADAPT Act (Accelerating Access to Dementia & Alzheimer's Provider Training Act), bipartisan legislation aimed at strengthening the dementia care workforce["@brain_health_roundtable"][@aadapt_press].

These initiatives represent a coordinated effort to address two critical gaps in dementia care: prevention and early risk reduction through brain health promotion, and the shortage of trained healthcare providers capable of detecting, diagnosing, and treating Alzheimer's and other dementias.

Brain Health Roundtable

Background and Purpose

The Alzheimer's Association Brain Health Roundtable was announced on March 17, 2026, as a cross-sector coalition working to elevate brain health as a national public health priority and accelerate the adoption of evidence-based strategies to reduce dementia risk[@brain_health_roundtable].

The initiative recognizes that while advances in Alzheimer's research have yielded important insights into disease mechanisms and potential treatments, there is a critical need to translate these findings into public health strategies that can help reduce dementia risk at the population level. The Brain Health Roundtable brings together stakeholders from multiple sectors to develop coordinated approaches to brain health promotion.

Coalition Objectives

The Brain Health Roundtable aims to:

Significance for Neurodegeneration Research

The Brain Health Roundtable represents an important shift in Alzheimer's and dementia policy toward prevention and risk reduction. While much of the research focus in recent decades has been on developing disease-modifying therapies, there is growing recognition that lifestyle modifications and public health interventions can complement pharmacological approaches. The Roundtable provides a mechanism for translating evidence-based brain health strategies into actionable public health programs.

The initiative aligns with the National Plan to Address Alzheimer's Disease, which includes goals for both treatment and prevention, and supports the broader objective of reducing the projected burden of dementia on individuals, families, and the healthcare system.

AADAPT Act

Legislative Overview

The Accelerating Access to Dementia & Alzheimer's Provider Training (AADAPT) Act was reintroduced in the U.S. Senate in March 2026 with strong bipartisan support. The bill is sponsored by Senators Shelley Moore Capito (R-W.Va.), Amy Klobuchar (D-Minn.), Jerry Moran (R-Kan.), Cory Booker (D-N.J.), Dan Sullivan (R-Alaska), Andy Kim (D-N.J.), James Lankford (R-Okla.), and Maria Cantwell (D-Wash.)[@aadapt_press][@alz_impact].

Problem Statement

The AADAPT Act addresses a critical gap in dementia care: the shortage of healthcare providers with specialized training in Alzheimer's and dementia detection, diagnosis, and treatment. Key statistics motivating the legislation include:

• Only half of those living with Alzheimer's disease have a formal diagnosis
• 85% of initial dementia diagnoses are made by primary care providers
• Many primary care providers lack specialized training in dementia care
• Rural and medically underserved areas face particularly acute shortages of dementia-trained providers

Key Provisions

The AADAPT Act authorizes grants for healthcare providers participating in structured virtual education programs focused on Alzheimer's and dementia care. The legislation offers:

• Early detection of cognitive impairment
• Accurate diagnosis of Alzheimer's and other dementias
• Evidence-based treatment approaches
• Ongoing care management
• Person-centered care strategies

Goals and Objectives

The AADAPT Act aims to:

• Improve Diagnosis Rates: Increase the proportion of people with Alzheimer's who receive a timely, accurate diagnosis
• Enhance Care Quality: Ensure that dementia care is delivered according to evidence-based best practices
• Expand Access: Reduce barriers to early diagnosis and quality dementia care, particularly in rural and underserved areas
• Support Primary Care: Equip primary care providers—who make the majority of initial dementia diagnoses—with the skills needed to provide high-quality care

Legislative Context

The AADAPT Act builds on previous congressional efforts to address the dementia workforce crisis. The legislation reflects growing recognition that advances in Alzheimer's detection and treatment will have limited impact if there are not enough trained providers to deliver care. By expanding access to continuing education and training, the bill aims to build workforce capacity across the healthcare system.

The Alzheimer's Impact Movement (AIM), the advocacy arm of the [Alzheimer's Association](/institutions/alzheimers-association), has made the AADAPT Act a key priority in its federal advocacy agenda[@alz_impact].

Interconnection and Policy Significance

The Brain Health Roundtable and AADAPT Act represent complementary approaches to addressing the Alzheimer's and dementia crisis:

Prevention and Early Intervention

Both initiatives emphasize early detection and intervention:

• The Brain Health Roundtable focuses on brain health promotion and dementia risk reduction at the population level
• The AADAPT Act aims to improve early diagnosis by training more providers to recognize and appropriately manage cognitive impairment

Addressing Healthcare Disparities

Both initiatives have explicit goals to address health disparities:

• The Brain Health Roundtable aims to ensure brain health strategies reach underserved communities
• The AADAPT Act specifically targets rural and medically underserved areas where primary care providers face the greatest strain

Building Infrastructure

Together, these initiatives help build the infrastructure needed for effective dementia care:

• The Brain Health Roundtable creates the public health framework for brain health promotion
• The AADAPT Act develops the workforce capacity needed to deliver quality dementia care

Related Topics

• [Alzheimer's Association](/institutions/alzheimers-association)
• [Alzheimer's Impact Movement](/institutions/alzheimers-association#alzheimers-impact-movement)
• [Dementia Care](/diseases/alzheimers-disease)
• [Alzheimer's Disease Research](/institutions/alzheimers-association#research-programs-and-funding)
• [Modifiable Risk Factors](/mechanisms/modifiable-risk-factors)
• [Neuroepidemiology](/diseases/disease-prevalence)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Brain Health Roundtable and AADAPT Act discovered through SciDEX knowledge graph analysis: